Editorial: screening for hepatocellular carcinoma in NAFLD —towards abbreviated MRI alternative in patients with obesity? - INRAE - Institut national de recherche pour l’agriculture, l’alimentation et l’environnement Accéder directement au contenu
Article Dans Une Revue Alimentary Pharmacology & Therapeutics (Suppl) Année : 2022

Editorial: screening for hepatocellular carcinoma in NAFLD —towards abbreviated MRI alternative in patients with obesity?

Dates et versions

hal-03658960 , version 1 (04-05-2022)

Identifiants

Citer

Fanny Lebossé, Cyrielle Caussy. Editorial: screening for hepatocellular carcinoma in NAFLD —towards abbreviated MRI alternative in patients with obesity?. Alimentary Pharmacology & Therapeutics (Suppl), 2022, 55 (9), pp.1210-1211. ⟨10.1111/apt.16887⟩. ⟨hal-03658960⟩
19 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More